Apoorva Daram, Shruti S. Sawant, Dhwani A. Mehta, Carlos A. Sanhueza, & Nitesh K. Kunda. (2024). Inhalable Anti-EGFR Antibody-Conjugated Osimertinib Liposomes for Non-Small Cell Lung Cancer. MDPI AG.
Chicago Style (17th ed.) CitationApoorva Daram, Shruti S. Sawant, Dhwani A. Mehta, Carlos A. Sanhueza, and Nitesh K. Kunda. Inhalable Anti-EGFR Antibody-Conjugated Osimertinib Liposomes for Non-Small Cell Lung Cancer. MDPI AG, 2024.
MLA (9th ed.) CitationApoorva Daram, et al. Inhalable Anti-EGFR Antibody-Conjugated Osimertinib Liposomes for Non-Small Cell Lung Cancer. MDPI AG, 2024.
Warning: These citations may not always be 100% accurate.